We are live on ! Find out more
JSP

Jackson Square Partners Portfolio holdings

AUM $247M
1-Year Est. Return 20.29%
This Fund
S&P 500
This Quarter Est. Return
+13.07%
1 Year Est. Return
+20.29%
3 Year Est. Return
+101.87%
5 Year Est. Return
+75.18%
10 Year Est. Return
+392.81%
AUM
$3.75B
AUM Growth
-$62.6M
Cap. Flow
-$395M
Cap. Flow %
-10.55%
Top 10 Hldgs %
44.95%
Holding
93
New
10
Increased
14
Reduced
56
Closed
12

Top Buys

Rank Stock Value
1
LSCC icon
Lattice Semiconductor
LSCC
+$65.1M
2
OKTA icon
Okta
OKTA
+$48.6M
3
SITE icon
SiteOne Landscape Supply
SITE
+$46M
4
FMC icon
FMC
FMC
+$38.5M
5
GO icon
Grocery Outlet
GO
+$30.8M

Sector Composition

Rank Sector Weight
1 Technology 22.47%
2 Industrials 20.06%
3 Healthcare 19.45%
4 Financials 11.17%
5 Communication Services 10.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWLO icon
76
Twilio
TWLO
$35.8B
-101,408
Closed -$7.01M
UPWK icon
77
Upwork
UPWK
$1.1B
-7,080,973
Closed -$96.4M
CTLT
78
DELISTED
CATALENT, INC.
CTLT
-1,458,029
Closed -$106M
FTCH
79
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
-6,518,189
Closed -$48.6M
ABMD
80
DELISTED
Abiomed Inc
ABMD
-428,103
Closed -$105M

Similar funds

Jackson Square Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Jackson Square Partners held 93 positions worth $3.75B, down 1.6% from $3.81B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Jackson Square Partners withdrew a net $395M in Q4 2022, closing 12 positions and reducing 56 holdings. Its most notable exit was CATALENT, INC., an estimated $106M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Jackson Square Partners opened a new position in Lattice Semiconductor worth $70M.

  • Jackson Square Partners's largest Q4 2022 buy was Lattice Semiconductor: 1,078,759 shares worth $70M.
  • Jackson Square Partners added most to SiteOne Landscape Supply in Q4 2022, an estimated $46M increase.
  • Jackson Square Partners's biggest Q4 2022 reduction was Pacific Biosciences, cutting an estimated $45.3M.
  • Jackson Square Partners fully exited CATALENT, INC. in Q4 2022, selling an estimated $106M.
  • Jackson Square Partners's ten largest holdings make up 45% of its $3.75B portfolio in Q4 2022.
  • Jackson Square Partners opened 10 new positions and closed 12 in Q4 2022.
  • Jackson Square Partners's portfolio value fell 1.6% quarter-over-quarter to $3.75B.

Based on Jackson Square Partners's 13F filing for Q4 2022, filed 9 Feb 2023.